QGEN - CIK 0001015820
The table below shows QIAGEN N.V.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $654.33M | $673.55M | $459.45M | $715.26M | $639.00M | $457.81M |
| Capital expenditure | $201.05M | $167.17M | $149.71M | $129.22M | $189.90M | $132.79M |
| Investing cash flow | -$305.28M | -$249.23M | -$87.66M | -$726.76M | -$202.43M | -$443.28M |
| Dividends paid | $54.24M | $0.00 | $0.00 | - | - |
QIAGEN N.V. reported operating cash flow of $654.33M for fiscal year 2025. That is down 2.9% from $673.55M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $341.60M (FY 2016) to $654.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $280.09M | $292.10M | $0.00 | $0.00 | $99.99M | $63.99M |
| Financing cash flow | -$178.98M | -$422.90M | -$433.83M | -$125.80M | -$150.37M | -$50.13M |